Latest Articles

Subject

Research Article
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis
Gertjan Peeters, Ann Van Remoortel, Guy Nagels, et al.

February 17, 2023
Research Article
Neurologic Manifestations of Common Variable ImmunodeficiencyImpact on Quality of Life
Bruno Ivo De Almeida, Tammy L. Smith, Alen Delic, et al.

February 16, 2023
Research Article
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis
Stephen L. Hauser, Amit Bar-Or, Martin S. Weber, et al.

February 15, 2023
Research Article
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
Melissa Sorosina, Silvia Santoro, Laura Ferrè, et al.

February 15, 2023
Correction & Replacement
Immune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies
February 08, 2023
Research Article
Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates
Florian Ingelfinger, Michael Kramer, Mirjam Lutz, et al.

February 08, 2023
Research Article
Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
Frederik Bartels, Birgit Baumgartner, Annette Aigner, et al.

February 08, 2023
Research Article
Ocrelizumab Impairs the Phenotype and Function of Memory CD8⁺ T CellsA 1-Year Longitudinal Study in Patients With Multiple Sclerosis
Amandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.

January 30, 2023
Research Article
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
Samantha Ho, Eva Oswald, Hoi Kiu Wong, et al.

January 26, 2023
Research Article
Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis
Rodrigo Álvarez-Velasco, Oriol Dols-Icardo, Shaima El Bounasri, et al.

January 25, 2023

Pages